ESR1 and breast cancer: In estrogen receptor positive/progesterone receptor positive (ER+/PR+) breast cancers, significant miRNAs such as miR-100 and the miR-30 family play essential roles, particularly in distinguishing between luminal A and luminal B molecular subtypes.